Professor Dame Anna Dominiczak
Professor Dame Anna Dominiczak DBE, MD, FRCP, FAHA, FRSE, FMedSci is Regius Professor of Medicine at the University of Glasgow as well as honorary consultant physician and non-executive member of NHS Greater Glasgow and Clyde Health Board. In 2016, she was awarded a DBE for services to cardiovascular and medical science.
Professor Dominiczak is one of the world’s leading cardiovascular scientists and clinical academics. She held a British Heart Foundation Chair of Cardiovascular Medicine at the University of Glasgow between 1997 and 2010, and directorship of the Cardiovascular Research Centre between 2000 and 2010. Her major research interests are in hypertension, cardiovascular genomics and precision medicine, where she not only publishes extensively in top peer-reviewed journals (over 400 publications), but also excels in large-scale research funding for programmes and infrastructure (with a total value in excess of £100M over the last seven years). She leads a collaboration of four universities, four academic NHS Health Boards across Scotland and two major industry partners in a public/private partnership focused on precision medicine, with a value in excess of £20M.
Professor Dominiczak is a Fellow of the Royal College of Physicians, the American Heart Association, the Academy of Medical Sciences, the Royal Society of Edinburgh, the European Society of Cardiology and the Society of Biology. She is a member of the British Medical Association, British Hypertension Society, European Society of Hypertension, International Society of Hypertension, British Endocrine Society, Association of Physicians of Great Britain and Ireland, American Physiological Society, British Atherosclerosis Society, British Cardiovascular Society and European Atherosclerosis Society. From 2013 to 2015, she was President of the European Society of Hypertension.
Since 2012, she has been Editor-in-Chief of Hypertension, journal of the American Heart Association and the world’s top journal in her area of research.
Professor David Harrison
Professor David Harrison MD, DSc, FRCPath, FRCPEd, FRCSEd graduated from the University of Edinburgh and trained as a histopathologist. Whilst clinically specialising in liver and kidney, his research interests are broader, coming under the general banner of systems biology and AI applied to pathology. He is currently Professor of Pathology in St Andrews, and Director of Development for Laboratory Medicine in NHS Lothian. David holds honorary chairs in Glasgow, Florida, Edinburgh, the last of these where he was Professor of Pathology for 12 years and Director of the Edinburgh Cancer Research Centre. Alongside his clinical and academic work, David is director in several small biotech companies, he chairs the UK Committee on Carcinogenicity and is Chairperson of a number of Charities. He is Director of iCAIRD (Industrial Centre for AI Research in Digital Diagnostics), a Scotland-wide consortium funded by Innovate UK.
Professor Alison Murray
Professor Lesley Anderson
Academic Lead, NHS Grampian/DaSH
Professor Lesley Anderson joined the Aberdeen Centre for Health Data Science in March 2020. She trained at Queen’s University Belfast (QUB) graduating with a PhD in cancer epidemiology in 2004 and an undergraduate degree (first class Honours) in Biomedical Science in 2001. She has a Masters in Population Health-based Evidence obtained by distance learning from the University of Manchester (distinction level) in 2006. Professor Anderson joined QUB as an academic in 2010 after completing two highly respected fellowships: an Academic Fellowship (funded by the UK Medical Research Council) and a Cancer Prevention Fellowship at the National Cancer Institute, National Institute of Health, Maryland, United States of America. Professor Anderson then joined the Northern Ireland Cancer Registry (NICR) part-time in 2017 as Deputy Director overseeing the production of Official Statistics for Northern Ireland and developing the NICR Research Advisory Group.
Professor Lesley Anderson has over 19 years experience in research utilising healthcare data from the United Kingdom, Ireland, USA and Europe. She has established international partnerships within the USA, Europe, Australia, Africa and Asia to facilitate research in the fields of health data science and public health with a focus on cancer research. Global Health Research Partnerships with researchers in Angola, Mongolia and Vietnam are seeking to identify ways to improve public knowledge and reduce the burden of cancer. Professor Anderson is working to improve health care through Health Data Science research.
Professor Corri Black
Academic Lead for Grampian Safe Haven
Professor Corri Black trained at the University of Glasgow graduating in 1996 and spent 5 years working in hospital medicine in Glasgow. She spent a year at the Boston Collaborative Drug Surveillance Programme, University of Boston, USA on a Research Scholarship studying Clinical and Pharmacoepidemiology. On return to the UK, she joined the University of Aberdeen as a Clinical Lecturer in 2002 and completed specialist training in Public Health Medicine before being appointed as a Senior Clinical Lecturer in Public Health and Honorary NHS Consultant in 2007. She was awarded a personal Chair in 2015.
Professor Corri Black is a Co-Director of the Aberdeen Centre for Health Data Science, Deputy Director of Farr Institute@Scotland, Associate Director of HDRUK@Scotland and has 18 years experience of harnessing electronic health record data for research. As a Consultant in Public Health, she works for NHS Grampian supporting the use of data to drive quality improvement and in population health surveillance. She is the Clinical Lead for the Grampian Data Safe Haven. Working with colleagues, her research has included real world data pharmaceutical research and now focuses on understanding complexity in health in long term conditions and across the life course. She currently serves as the Grampian Safe Haven Academic Lead for iCAIRD.
Professor Roger Staff
Clinical Imaging Expert, Grampian
Professor Roger Staff was born in London and studied physics at UEA. He moved to Aberdeen in 1988 and completed his PhD in medical physics in 1994. He has worked for the NHS since 1991 and currently leads the clinical physics imaging team at NHS-Grampian. His other interests include Intelligence and social mobility.
Dr Gareth Bryson
Dr Gareth Bryson is a consultant pathologist at the Queen Elizabeth University Hospital, where he has also held the role of Head of Service for Pathology since 2016. Gareth’s areas of expertise include gynaecological and urological pathology. His non-clinical interests include efficient systems, laboratory modernisation and workload measurement and digital pathology. He is the Scottish Lead for Digital Pathology. Within iCAIRD, Gareth is leading on the full digitisation of NHS GGC Pathology within the lifetime of the programme. He is also contributing to the exemplar projects with colleagues from University of St Andrews and Philips. He currently serves as Pathology Expert on the Governance Board.
Dr David Stirling
National NHS Services Scotland Board representative
Dr David Stirling is a registered clinical scientist and Fellow of the Royal College of Pathologists. He is currently the Director of Healthcare Science for NHS National Services Scotland and a Consultant Clinical Scientist for NHS Lothian. Prior to this he was the Scottish national professional lead for Healthcare Science.
He has over 28 years’ experience as a clinical scientist and led the introduction of Haematology Molecular testing in NHS Lothian, leading to a National service for genetics of bleeding disorders, and the introduction of molecular pathology testing. Prior to specialising in Haematology, David was involved in research at the University of Texas, and the Imperial Cancer Research Fund.
Previously a member of the Academy for Healthcare Science Regulation Council and a Director of the Association of Clinical Scientists, David is the Boards’ NSS representative.
Professor Mark Parsons
Edinburgh Parallel Computing Centre Board representative
Professor Mark Parsons holds a Personal Chair in High Performance Computing at the University of Edinburgh. He is the Director of EPCC, the University of Edinburgh’s supercomputing centre, a position he has held since 2016. He is also the Associate Dean for e-Research in the College of Science and Engineering, a role he has held since 2010. Professor Parsons joined EPCC following his PhD at CERN in 1994 to work as a software developer.
Professor Julie Brittenden
Academic Lead, NHS GG&C Safe Haven
Professor Julie Brittenden graduated from the University of Aberdeen in 1988 and obtained a Doctor of Medicine with honours in 1995. She has worked in Aberdeen & Edinburgh before moving to Glasgow in 2015. Julie is Professor of Vascular Surgery at Glasgow University, Director of Research & Development for NHS GGC and Director of the joint Glasgow University & NHS GGC Clinical Research Facilities.
Her research interests include cardiac risk factor management & novel biomarkers in patients with peripheral arterial disease; evaluating and imaging of unstable carotid plaques. She is Chief Investigator of RCTs of innovative venous therapies and devices to improve physical activity in patients with PAD.
Julies’ current responsibilities include membership of the following; Management board for NHS Research Scotland, the NRS oversight Board Health Science Scotland, Life Sciences Scotland Industry Leadership Group and Scottish Health Innovations Ltd, in addition to the NIHR HTA General Board Panel & Venous Forum Council. She is specialists advisor to the Scottish Medicines Consortium (2003-present) and reviewer for the Scottish health Technology Group.
Julie serves a dual role as Data Officer/ Glasgow Safe Haven Academic Lead for iCAIRD on the Governance Board.
Director of eHealth, NHS GG&C
William Edwards was appointed as the Director of eHealth at NHS Greater Glasgow and Clyde in July 2017, having been the Interim Director since November 2016. He has held a number of senior national and local ICT roles since joining the NHS in June 1999. He was formerly the Head of eHealth at the NHS Scotland NWTC Board/Golden Jubilee Hospital and General Manager – eHealth at NHS Fife before joining NHS Greater Glasgow and Clyde
Dr Ken Sutherland
Industry partner representative (Canon)
Dr Ken Sutherland is President of Canon Medical Research Europe. He is a Director on Canons’ Board and responsible for all aspects of the strategic development and operational control within Canon Medical Research Europe Ltd and is also a key member of Canon Medical Systems Global R&D leadership team.
He serves as a member of the Scottish Government Inward Investment Forum, a lay member of the Court of Glasgow University and as an advisory board member of the Scottish Lifesciences Association. He was recently admitted as a Fellow of the Royal Society of Edinburgh.
Ken studied Electronics and Computer Science at Edinburgh University and gained a PhD in image analysis and four years postdoctoral research experience in medical image analysis. He returned to Edinburgh in August 2007 to join Canon Medical as R&D General Manager following his previous post of Operations Director for a European multinational where he was responsible for their imaging R&D facility in Cambridge, England. Ken currently serves as Canon representative on the iCAIRD Governance Board
Industry partner representative (Canon)
Andy Smout is Vice President, Research at Canon Medical Research Europe, with overall responsibility for technology research, advanced development, intellectual property and software architecture. He has extensive experience in designing, building and supporting large scale software systems and has recently been responsible for the establishment of Canon Medical’s global Centre of Excellence for Artificial Intelligence in Edinburgh.
After gaining his PhD in Quantum Electronics from the University of Essex, Andy worked in factory process control and semiconductor lithographic overlay metrology before joining Canon Medical in 2000. He worked for many years as Technical Lead of the Custom Solutions division, and following a brief period as Engineering Manager for Voxar 3D he transitioned to Chief Architect in 2007, Group Leader of Infrastructure in 2010, and finally Vice President for Research in 2013. Andy has been awarded a number of patents; however his proudest achievement was to have a seminal paper on “Mutually Incoherent Beam Coupling in BaTiO32” published in 1987, which has now received 142 citations. He currently serves on the Governance Board as a Canon representative.
Dr Ignat Drozdov
Board SME partner representative
Dr Ignat Drozdov is managing director of Bering Ltd. He is an SME partner representative and co-chair for the Board.
Board SME partner representative
Sarah Kerruish is Chief Strategy Officer of Kheiron Medical. She is an SME partner representative and co-chair for the Board.